Device/Diagnostics Quarterly Deal Statistics, Q3 2013
A look at financing, M&A, and alliance activity, July–September 2013
Device and diagnostics companies both suffered declines in fundraising compared with previous quarters. The biggest medtech acquisition was Stryker’s $1.4 billion buyout of MAKO, while in diagnostics BioMeriux’s $450 million purchase of BioFire topped the list.